Diagnostics is currently driven by Healthcare. The recent article tape shows 30 bullish, 3 bearish, and 3 neutral reads across 4 sources.
Updated 25 Aug 2026, 3:11 pm IST · Sentiment is computed from saved analyzed news and quote snapshots.
Diagnostics has 36 recent analyzed stories in this hub, with a sector bias score of +37. The dominant cluster is Healthcare, and the story breadth is 30 bullish, 3 bearish, and 3 neutral reads.
The most repeated listed names are THYROCARE, LALPATHLAB, LUPIN, DRL, DIVISLAB. These are the names drawing the most coverage; quote movement, volume, and company-specific context add further reference.
The IT and telecom sectors are seeing increased demand for enterprise solutions, especially with 5G rollout. This deal highlights the growing convergence of IT/telecom with traditional industries like automotive, creating new revenue streams.
Economic Times · 6 days ago · 2 min read
Economic Times · 11 days ago · 2 min read
Economic Times · 11 days ago · 2 min read
Economic Times · 12 days ago · 2 min read
Economic Times · 13 days ago · 2 min read
Diagnostics coverage is leaning bullish across 36 recent stories from 4 sources. The article split is 30 bullish, 3 bearish, and 3 neutral.
The strongest article-driven stock reads in this hub are LALPATHLAB (+55), LUPIN (+50), DRL (+49). These scores are based on saved article impact, not a standalone buy signal.
The weakest article-driven stock reads in this hub are THYROCARE (-61). Check quote confirmation and fresh coverage before acting.
Recent Diagnostics coverage is clustering around Healthcare, Diagnostics, Broad_market.